The EEF1A2 gene helps nerve and muscle cells make proteins, which they need to send signals and stay healthy. This gene plays an important role in brain and muscle function throughout life. If the EEF1A2 gene does not work properly, people may have seizures, developmental delay, low muscle tone, or unusual movements. Harmful variants in this gene are uncommon but can be a direct cause of a genetic condition affecting the brain and nervous system.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Others mostly help regulate when certain processes take place, where they happen, and how strongly they occur. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
EEF1A2Gene function
What if the gene works
The EEF1A2 gene helps cells build proteins by moving amino acid building blocks into place. It is especially active in the brain, heart, and muscles, where it supports normal cell function and survival.
Risk
What if the gene does not work
Variants in the EEF1A2 gene are linked to a neurodevelopmental condition, often with developmental delay, epilepsy, low muscle tone, or movement differences. Effects can range from milder learning difficulties to earlier, more complex symptoms, depending on the variant.
Treatment
What does that mean for your treatment
No EEF1A2-specific treatment or drug choice is currently established in clinical guidelines. Care is based on the person's symptoms rather than the EEF1A2 variant itself. The EEF1A2 gene is also being studied in cancer research as a possible drug target and biomarker.
Conditions associated with EEF1A2
Gene function
What if the gene works
Your cells need a constant supply of new proteins for movement, signaling, and repair. The EEF1A2 gene helps keep protein production moving, especially in nerve cells and muscle. This helps explain what the EEF1A2 gene does in the brain and muscles during everyday cell activity.
The EEF1A2 gene helps carry amino acid building blocks to the ribosome, the cell’s protein making site. This lets the cell add each building block in the correct order as a protein is made.
Inside your cells, the EEF1A2 gene supports the step by step reading of messenger RNA, the instruction copy used to build proteins. This keeps protein production smooth during normal cell activity.
In mature nerve cells and in heart and skeletal muscle, cells mainly use the protein made from the EEF1A2 gene for protein production. It supports the steady protein supply these active tissues need for signaling, contraction, and routine upkeep.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change how a gene functions more substantially, and this may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many EEF1A2 gene variants change the shape or stability of the protein, so it may not bind its partners inside cells in the usual way. In this overview of how EEF1A2 gene variants affect protein function, milder changes may partly reduce activity, while more disruptive variants can greatly weaken the protein or create an abnormal form that interferes with nearby cell machinery. These larger functional changes are often linked to earlier onset or more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the EEF1A2 gene are a recognized cause of developmental and epileptic encephalopathy, a group of conditions marked by seizures and developmental difficulties. Many people with an EEF1A2 gene variant and epilepsy also have intellectual disability, low muscle tone, or movement problems such as dystonia or ataxia. Severity varies from person to person, but these variants are part of a confirmed genetic diagnosis rather than a general risk marker.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the EEF1A2 gene. For many living with a disease-causing change in EEF1A2, the main risk is driven by the genetic change itself rather than lifestyle or environmental factors. Anyone worried about personal or family risk can speak with a doctor or genetic counselor.
Inheritance of EEF1A2 variants
EEF1A2-related conditions usually follow an autosomal dominant inheritance pattern, which helps answer how EEF1A2 variants are inherited in families. This means a person with a disease-causing variant in one copy of the EEF1A2 gene can pass it on to each child with a 50% chance. Many reported cases happen because of a new (de novo) variant, so the change is not inherited from either parent. In families where a parent carries the variant, it can be passed to sons and daughters alike.
What does my EEF1A2 result mean for my family?
For EEF1A2, a disease-causing result is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, though, the change happened new in the affected child and was not inherited from either parent. That means the meaning for relatives often depends on whether the variant was inherited or happened for the first time in one family member.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the EEF1A2 gene, a lab can analyze DNA from a blood sample or cheek swab. This is how genetic testing for EEF1A2 variants works: the lab reads the gene’s code and compares it with the usual sequence to look for variants linked to symptoms or a diagnosed condition.
When should I consider getting a genetic test?
Genetic testing may be worth discussing if a child has unexplained developmental delay, seizures, unusual movements, or low muscle tone, especially if these start early in life. Testing for changes in the EEF1A2 gene can sometimes help explain the cause and confirm a genetic condition.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they reveal varies with the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines because the body does not handle every drug in the same way. Some people break down a medication more slowly or more quickly, while others may be more or less sensitive to its effects. This common variation can influence how well a treatment works and whether side effects are more likely.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can shape a person’s response to medication. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body handles it. This understanding can support better informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the EEF1A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines. For questions about side effects, new symptoms, or whether a treatment is the right fit, talk with your doctor or pharmacist.